or Try an Advanced Search...

    Technical Analysis for KRRO - Korro Bio, Inc.

    Grade Last Price % Change Price Change
    B 58.16 1.15% 0.66
    KRRO closed up 1.15 percent on Friday, November 1, 2024, on 65 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical KRRO trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish 0.00%
    1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
    Earnings Movers Other 0.00%
    Multiple of Ten Bearish Other 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    20 DMA Support Bullish 1.15%
    Earnings Movers Other 1.15%
    Multiple of Ten Bearish Other 1.15%
    Older End-of-Day Signals for KRRO ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 19 hours ago
    Up 5% about 21 hours ago
    20 DMA Support about 23 hours ago
    Down 2 % about 24 hours ago
    Down 1% about 24 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    KRRO Chart by TradingView
    Basic chart:

    Profile

    Korro is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling treatment of both rare and highly prevalent diseases. Korro's lead program in AATD has demonstrated an increase of normal A1AT protein up to 85% of total A1AT protein in circulation in in vivo preclinical studies, which has the potential of disease-modifying effects and providing a differentiated therapeutic option.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Hepatology Alpha 1 Antitrypsin Alpha 1 Antitrypsin Deficiency

    Is KRRO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 21 Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space.
    Oct 16 Wave Life Sciences Just Edited RNA. Why Its Key Rival, Korro Bio, Skyrocketed.
    Sep 30 Korro Announces Oral and Poster Presentations at the 20th Annual Meeting of the Oligonucleotide Therapeutics Society
    Sep 16 Korro Bio Announces Collaboration with Novo Nordisk to Develop Two Therapeutic Candidates
    Sep 4 Will Korro Bio (NASDAQ:KRRO) Spend Its Cash Wisely?
    Aug 28 Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors
    Aug 27 Korro to Participate in Upcoming September Investor and Scientific Conferences
    Aug 14 Korro Bio GAAP EPS of -$2.43 beats by $0.29
    Aug 13 Korro Reports Second Quarter 2024 Financial Results and Provides Business Updates
    Jul 3 Korro Bio: Interesting RNA Biotech With 2nd Half 2025 Interim Data
    See more KRRO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 98.0
    52 Week Low 14.0
    Average Volume 112,720
    200-Day Moving Average 51.09
    50-Day Moving Average 46.81
    20-Day Moving Average 57.57
    10-Day Moving Average 65.35
    Average True Range 6.60
    RSI (14) 53.70
    ADX 33.91
    +DI 31.54
    -DI 22.26
    Chandelier Exit (Long, 3 ATRs) 78.20
    Chandelier Exit (Short, 3 ATRs) 50.52
    Upper Bollinger Bands 89.81
    Lower Bollinger Band 25.32
    Percent B (%b) 0.51
    BandWidth 112.04
    MACD Line 5.46
    MACD Signal Line 6.72
    MACD Histogram -1.2585
    Fundamentals Value
    Market Cap 465.95 Million
    Num Shares 8.01 Million
    EPS
    Price-to-Sales 0.00
    Price-to-Book 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 65.31
    Resistance 3 (R3) 65.42 63.15 64.12
    Resistance 2 (R2) 63.15 61.33 63.10 63.72
    Resistance 1 (R1) 60.66 60.21 59.52 60.54 63.32
    Pivot Point 58.39 58.39 57.82 58.33 58.39
    Support 1 (S1) 55.89 56.57 54.76 55.78 53.00
    Support 2 (S2) 53.62 55.44 53.57 52.60
    Support 3 (S3) 51.13 53.62 52.20
    Support 4 (S4) 51.01